Close



Jan 5, 2023 08:00AM
Jan 5, 2021 08:00AM
Jan 8, 2020 08:00AM
Apr 11, 2019 09:22AM
Feb 19, 2019 08:56AM
Jan 7, 2019 07:07AM
Jan 7, 2019 07:00AM Intercept Announces NASH and PBC Program Updates
Jan 2, 2019 04:05PM
Dec 7, 2018 02:53PM
Feb 7, 2018 09:28AM
Jan 10, 2018 01:01PM
Dec 13, 2017 09:13AM
Nov 1, 2017 09:27AM
Sep 25, 2017 10:16AM Top 5 Performing Biotech Shorts in 2017 - S3 Partners
Sep 22, 2017 09:29AM
Jan 4, 2017 04:05PM
Oct 14, 2016 09:21AM
Apr 8, 2016 10:30AM
Apr 8, 2016 09:30AM
Apr 7, 2016 10:28AM
Mar 30, 2016 11:01AM Notable Analyst Rating Changes 3/30: (AAPL) (SHAK) (AIG) Upgraded; (INOV) (CMP) (SWN) Downgraded
Dec 15, 2015 12:53PM
Dec 15, 2015 09:24AM
Dec 15, 2015 07:03AM
May 19, 2015 09:28AM
Apr 17, 2015 10:24AM
Feb 5, 2015 09:21AM
Jan 12, 2015 08:01AM Intercept Pharma (ICPT) Updates on Expected FY15 Milestones; Sees OCA NASH Phase 3 in H215
Jan 12, 2015 08:00AM
Jan 7, 2015 04:05PM
Jan 5, 2015 12:18PM
Oct 7, 2014 09:29AM
Aug 12, 2014 10:49AM
Jul 30, 2014 09:32AM
Jul 2, 2014 10:50AM Notable Analyst Rating Changes 07/02: (ABBV) (ALU) (BAC) Upgraded; (TRMB) (HOG) (EPB) Downgraded
Jul 1, 2014 09:34AM
Jun 30, 2014 05:50PM
May 29, 2014 09:29AM
May 15, 2014 10:28AM
Apr 1, 2014 12:18PM
Jan 15, 2014 12:25PM
Jan 15, 2014 10:54AM Intercept Pharma (ICPT) Plans Filing for Accelerated Aprroval of OCA for PBC

208,977 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All